TAKE A LOOK AT WHICH REPORT YOUR PORTFOLIO'S BEEN MISSING...

Shareholders Foundation offers real-time reporting of class action exposure on a per transaction basis,
including the documents you will need for claim filing and settlement recovery.
Start Monitoring Your Investments
  • Shareholders Foundation monitors Class Action Investigations, Cases, and Class Action Settlements.
    Learn More >>>
  • Create Notifications and monitor one Case or multiple Cases. Or submit your entire portfolio! Learn More >>>

ZIOPHARM Oncology Inc. (NASDAQ:ZIOP) Investor Investigation Over Potential Securities Laws Violations Announced

  • If you purchased shares of ZIOPHARM Oncology Inc. (NASDAQ:ZIOP), you have certain options and you should contact the Shareholders Foundation, Inc.

  • To have your information reviewed for options and to receive notifications about this case, please use this form. You may also send an email to mail@shareholdersfoundation.com, or call us at (858) 779-1554.

Site Members can sign up for company wide alerts

Investigation Overview

July 25, 2016 - On July 14, 2016, ZIOPHARM Oncology Inc revealed that a brain cancer patient in an ongoing clinical trial had died after being treated with Ad-RTS-hIL-12, the Company's experimental gene therapy. A Ziopharm spokesman commented that ZIOPHARM Oncology Inc had not yet informed the U.S. Food and Drug Administration of the death. ZIOPHARM Oncology Inc then disclosed a secon...



You must register (for free) or login to view the entire investigation.

Click here to Sign In or Register (for a free account)